Subgroup analysis in haematologic malignancies phase III clinical trials: A systematic review.
Nerea Báez-GutiérrezHéctor Rodríguez-RamalloSandra Flores-MorenoLaila Abdel-Kader MartínPublished in: British journal of clinical pharmacology (2020)
The subgroup claims reported in haematology RCTs lack credibility, even when the claims are strong. Information about subgroup difference should be interpreted cautiously.